Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis

OBJECTIVES: The aim of this study was to estimate lowest possible treatment costs for four novel cancer drugs, hypothesising that generic manufacturing could significantly reduce treatment costs. SETTING: This research was carried out in a non-clinical research setting using secondary data. PARTICIP...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Redd, Christopher, Gotham, Dzintars, Erbacher, Isabelle, Meldrum, Jonathan, Harada, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253524/
https://www.ncbi.nlm.nih.gov/pubmed/28110283
http://dx.doi.org/10.1136/bmjopen-2016-011965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253524/
https://www.ncbi.nlm.nih.gov/pubmed/28110283
http://dx.doi.org/10.1136/bmjopen-2016-011965

Ejemplares similares